ESR1 and neoplasm: Chemo-hormonal therapies are increasingly used to combat disease progression and prolong therapeutic efficacy in patients with tumor biopsies showing cells with estrogen receptor (ER), progesterone receptor (PR), and human EGF receptor 2 (HER2) positivity [4,5].